title: miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer.
abstract: The disabled homolog 2 (DAB2) gene was recently identified as a tumor suppressor gene with its expression downregulated in multiple cancer types. The role of DAB2 in lung tumorigenesis, however, is not fully characterized, and the mechanisms of DAB2 dysregulation in lung cancer are not defined. Here we show that low DAB2 levels in lung tumor specimens are significantly correlated with poor patient survival, and that DAB2 overexpression significantly inhibits cell growth in cultured lung cancer cells, indicating its potent tumor suppressor function. We next identify that microRNA miR-93 functions as a potent repressor of DAB2 expression by directly targeting the 3'UTR of the DAB2 mRNA. Using in vitro and in vivo approaches, we demonstrate that miR-93 overexpression has an important role in promoting lung cancer cell growth, and that its oncogenic function is primarily mediated by downregulating DAB2 expression. Our clinical investigations further indicate that high tumor levels of miR-93 are correlated with poor survival of lung cancer patients. The correlations of both low DAB2 and high miR-93 expression levels with poor patient survival strongly support the critical role of the miR-93/DAB2 pathway in determining lung cancer progression.
authors.affiliation: 1] Greehey Children's Cancer Research Institute, UT Health Science Center at San Antonio, San Antonio, TX, USA [2] Department of Cellular and Structural Biology, UT Health Science Center at San Antonio, San Antonio, TX, USA.
authors.forename: L
authors.initials: L
authors.lastname: Du
authors.affiliation: Greehey Children's Cancer Research Institute, UT Health Science Center at San Antonio, San Antonio, TX, USA.
authors.forename: Z
authors.initials: Z
authors.lastname: Zhao
authors.affiliation: Greehey Children's Cancer Research Institute, UT Health Science Center at San Antonio, San Antonio, TX, USA.
authors.forename: X
authors.initials: X
authors.lastname: Ma
authors.affiliation: Greehey Children's Cancer Research Institute, UT Health Science Center at San Antonio, San Antonio, TX, USA.
authors.forename: T-H
authors.initials: TH
authors.lastname: Hsiao
authors.affiliation: 1] Greehey Children's Cancer Research Institute, UT Health Science Center at San Antonio, San Antonio, TX, USA [2] Department of Epidemiology & Biostatistics, UT Health Science Center at San Antonio, San Antonio, TX, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Chen
authors.affiliation: Greehey Children's Cancer Research Institute, UT Health Science Center at San Antonio, San Antonio, TX, USA.
authors.forename: E
authors.initials: E
authors.lastname: Young
authors.affiliation: Department of Thoracic/Head and Neck Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: M
authors.initials: M
authors.lastname: Suraokar
authors.affiliation: 1] Department of Thoracic/Head and Neck Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, USA [2] Department of Translational Molecular Pathology, UT MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: I
authors.initials: I
authors.lastname: Wistuba
authors.affiliation: Hamon Center for Therapeutic Oncology Research and Departments of Pharmacology and Internal Medicine, UT Southwestern Medical Center at Dallas, Dallas, TX, USA.
authors.forename: J D
authors.initials: JD
authors.lastname: Minna
authors.affiliation: 1] Greehey Children's Cancer Research Institute, UT Health Science Center at San Antonio, San Antonio, TX, USA [2] Department of Cellular and Structural Biology, UT Health Science Center at San Antonio, San Antonio, TX, USA [3] Department of Pediatrics, UT Health Science Center at San Antonio, San Antonio, TX, USA.
authors.forename: A
authors.initials: A
authors.lastname: Pertsemlidis
mesh_terms: D020413:3' Untranslated Regions; D048868:Adaptor Proteins, Signal Transducing / Q000235:genetics* / Q000378:metabolism; D000818:Animals; D051017:Apoptosis Regulatory Proteins; D001483:Base Sequence; D001665:Binding Sites; D002289:Carcinoma, Non-Small-Cell Lung / Q000235:genetics* / Q000378:metabolism / Q000401:mortality; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D018572:Disease-Free Survival; D005260:Female; D059585:G1 Phase Cell Cycle Checkpoints; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D053208:Kaplan-Meier Estimate; D008175:Lung Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000401:mortality; D051379:Mice; D008819:Mice, Nude; D035683:MicroRNAs / Q000502:physiology*; D009368:Neoplasm Transplantation; D009857:Oncogenes; D011401:Promoter Regions, Genetic; D016016:Proportional Hazards Models; D034622:RNA Interference; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D025521:Tumor Suppressor Proteins / Q000235:genetics* / Q000378:metabolism
chemical_list: D020413:3' Untranslated Regions; D048868:Adaptor Proteins, Signal Transducing; D051017:Apoptosis Regulatory Proteins; C102885:DAB2 protein, human; C543350:MIRN93 microRNA, human; D035683:MicroRNAs; D012333:RNA, Messenger; D025521:Tumor Suppressor Proteins
references.citation: Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4400-6
references.pmid: 17671122
references.citation: Mol Cell. 2007 Jul 6;27(1):91-105
references.pmid: 17612493
references.citation: PLoS One. 2012;7(1):e29275
references.pmid: 22238599
references.citation: Cancer Cell. 2008 Mar;13(3):272-86
references.pmid: 18328430
references.citation: J Bone Miner Res. 2012 Jul;27(7):1598-606
references.pmid: 22467200
references.citation: Nat Struct Mol Biol. 2011 Sep 11;18(10):1139-46
references.pmid: 21909094
references.citation: Semin Oncol. 1985 Sep;12(3):289-303
references.pmid: 2996148
references.citation: Nucleic Acids Res. 2009 Apr;37(5):1672-81
references.pmid: 19153141
references.citation: Oncogene. 2012 Dec 13;31(50):5162-71
references.pmid: 22286770
references.citation: J Biol Chem. 2010 Jul 23;285(30):23457-65
references.pmid: 20501654
references.citation: Oncogene. 2011 Feb 17;30(7):806-21
references.pmid: 20956944
references.citation: Hum Pathol. 2011 Oct;42(10):1491-8
references.pmid: 21496867
references.citation: Mol Cancer Res. 2009 Aug;7(8):1234-43
references.pmid: 19671678
references.citation: Int J Oncol. 2010 Nov;37(5):1315-21
references.pmid: 20878079
references.citation: Oncogene. 2012 Feb 23;31(8):1034-44
references.pmid: 21765466
references.citation: Clin Cancer Res. 2008 Jan 1;14(1):41-7
references.pmid: 18172250
references.citation: Genome Res. 2009 Jan;19(1):92-105
references.pmid: 18955434
references.citation: Am J Pathol. 2006 Jul;169(1):258-67
references.pmid: 16816378
references.citation: J Biol Chem. 2001 Jul 20;276(29):26814-8
references.pmid: 11359772
references.citation: Clin Chest Med. 1982 May;3(2):389-98
references.pmid: 6284438
references.citation: Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):264-9
references.pmid: 20018759
references.citation: Oncogene. 1999 May 20;18(20):3104-13
references.pmid: 10340382
references.citation: Mol Endocrinol. 2012 Jun;26(6):1028-42
references.pmid: 22556343
references.citation: J Clin Invest. 2007 Sep;117(9):2713-22
references.pmid: 17717605
references.citation: World J Gastroenterol. 2006 Oct 7;12(37):6041-5
references.pmid: 17009406
references.citation: Endocrinology. 1998 Aug;139(8):3542-53
references.pmid: 9681506
references.citation: PLoS One. 2012;7(6):e39167
references.pmid: 22723956
references.citation: Cancer Res. 2005 Nov 1;65(21):9906-13
references.pmid: 16267015
references.citation: Cancer Res. 2008 Nov 1;68(21):8976-85
references.pmid: 18974142
references.citation: J Clin Invest. 2010 Aug;120(8):2842-57
references.pmid: 20592473
references.citation: Science. 1996 Apr 12;272(5259):263-7
references.pmid: 8602510
references.citation: BMC Cancer. 2011 Aug 10;11:347
references.pmid: 21831295
references.citation: J Cell Mol Med. 2012 May;16(5):1106-13
references.pmid: 21762377
references.citation: Cancer Sci. 2009 Jul;100(7):1234-42
references.pmid: 19486339
references.citation: Oncogene. 2012 Feb 9;31(6):764-75
references.pmid: 21725366
references.citation: FEBS Lett. 2012 May 7;586(9):1279-86
references.pmid: 22465665
references.citation: PLoS One. 2012;7(8):e43268
references.pmid: 22937028
references.citation: Oncogene. 2002 Aug 22;21(37):5804-13
references.pmid: 12173052
references.citation: Oncogene. 1998 May 7;16(18):2381-7
references.pmid: 9620555
references.citation: Breast Cancer Res Treat. 2007 Sep;104(3):277-86
references.pmid: 17115114
references.citation: Cell Cycle. 2012 Dec 1;11(23):4352-65
references.pmid: 23111389
references.citation: APMIS. 2013 Feb;121(2):111-9
references.pmid: 23030416